Could two drugs beat one for kidney recovery?
NCT ID NCT04743739
Summary
This study aimed to see if using two drugs together (rituximab and cyclosporine) works better than using just one (rituximab alone) to treat a specific kidney disease called idiopathic membranous nephropathy. The goal was to help patients achieve remission, meaning their urine protein levels drop significantly and kidney function stabilizes. The trial was terminated early after enrolling only 12 participants, so the results are limited.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC MEMBRANOUS NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Luhe Hospital, Capital Medical University
Beijing, Beijing Municipality, 101149, China
-
Beijing Tongren Hospital， Capital Medical University
Beijing, Beijing Municipality, 100730, China
-
Fuwai Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100037, China
-
Nanyang Nanshi Hospital, Henan University
Nanyang, Henan, 473065, China
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
-
The First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, 830054, China
-
The Seventh Affiliated Hospital, Sun Yat-sen University
Shenzhen, Shenzhen, China
Conditions
Explore the condition pages connected to this study.